Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.19 | N/A | -22.76% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.19 | N/A | -22.76% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed a cautious optimism about future performance. They highlighted ongoing efforts to improve operational efficiency.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.
The earnings report indicates that Prestige Consumer HE fell short of expectations on EPS, which contributed to a slight decline in stock price. The management's cautious tone suggests they are aware of current challenges but remain focused on long-term strategies. Investors may need to consider the lack of guidance as a sign of uncertainty in the near term.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HUMANA INC
Feb 6, 2012